Targeted alpha therapy of mCRPC: Dosimetry estimate of (213)Bismuth-PSMA-617

PURPOSE: PSMA-617 is a small molecule targeting the prostate-specific membrane antigen (PSMA). In this work, we estimate the radiation dosimetry for this ligand labeled with the alpha-emitter (213)Bi. METHODS: Three patients with metastatic prostate cancer underwent PET scans 0.1 h, 1 h, 2 h, 3 h, 4...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Nucl Med Mol Imaging
Autors principals: Kratochwil, Clemens, Schmidt, Karl, Afshar-Oromieh, Ali, Bruchertseifer, Frank, Rathke, Hendrik, Morgenstern, Alfred, Haberkorn, Uwe, Giesel, Frederik L.
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2017
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5700223/
https://ncbi.nlm.nih.gov/pubmed/28891033
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-017-3817-y
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars